Pulmonary Clinical Trial - United Therapeutics

Status:

Startup

ClinicalTrials.gov:

NCT05203510

Artisan - REM-PH-418

Drug

Parenteral Treprostinil/Oral Treprostinil

Phase

IV

Condition

Pulmonary Arterial Hypertension